Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks
Open accessPublished version of a preprint
Abstract
Here, we present Perturb-ATAC, a method that combines multiplexed CRISPR interference or knockout with genome-wide chromatin accessibility profiling in single cells based on the simultaneous detection of CRISPR guide RNAs and open chromatin sites by assay of transposase-accessible chromatin with sequencing (ATAC-seq). We applied Perturb-ATAC to transcription factors (TFs), chromatin-modifying factors, and noncoding RNAs (ncRNAs) in ∼4,300 single cells, encompassing more than 63 genotype-phenotype relationships. Perturb-ATAC in human B lymphocytes uncovered regulators of chromatin accessibility, TF occupancy, and nucleosome positioning and identified a hierarchy of TFs that govern B cell state, variation, and disease-associated cis-regulatory elements. Perturb-ATAC in primary human epidermal cells revealed three sequential modules of cis-elements that specify keratinocyte fate. Combinatorial deletion of all pairs of these TFs uncovered their epistatic relationships and highlighted genomic co-localization as a basis for synergistic interactions. Thus, Perturb-ATAC is a powerful strategy to dissect gene regulatory networks in development and disease.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper introduces Perturb-ATAC, a single-cell method that pairs CRISPR interference or knockout with ATAC-seq to link genetic perturbations to chromatin accessibility phenotypes. It applies the method in human B lymphoblasts and primary keratinocytes to map regulatory networks, differentiation modules, and epistatic interactions among transcription factors.
Key findings
- Perturb-ATAC detected guide RNAs or guide barcodes together with chromatin accessibility in thousands of single cells: 2,936 B lymphoblasts and 1,356 primary keratinocytes, covering 63 genotype-phenotype relationships.
- In GM12878 B cells, a 40-genotype screen across 2,627 cells identified accessibility changes at 10,103 open chromatin sites and 833 features; EZH2 depletion increased accessibility at H3K27me3-marked regions (chromVAR gain 0.78, FDR < 0.0001), while SPI1 depletion reduced SPI1-motif accessibility (loss 2.17, FDR < 0.0001).
- In keratinocytes, single-cell ATAC-seq defined three sequential regulatory modules during differentiation, and a CRISPR knockout screen of JUNB, KLF4, ZNF750, CEBPA, and EHF in 279 single-sgRNA and 235 double-sgRNA cells identified 399 altered features and showed that CEBPA loss biased cells toward early differentiation while KLF4 loss shifted cells later.
- Epistasis analysis classified 344 additive, 102 synergistic, and 101 buffering interactions; synergistic TF pairs showed greater target-region overlap (Spearman correlation = 0.4) and correlated expression across tissues (Spearman correlation = 0.358).
Methods
- Perturb-ATAC was performed on microfluidic integrated fluidic circuits, combining cell lysis, Tn5 transposition, reverse transcription of sgRNAs or guide barcodes, and PCR amplification before sequencing of ATAC and guide libraries.
- The B lymphoblast experiments used dCas9-KRAB CRISPRi targeting transcription factors, chromatin modifiers, and noncoding RNAs, with single- and dual-guide genotypes; the keratinocyte experiments used Cas9-mediated knockout of selected transcription factors, followed by differentiation and harvest at Day 3.
- Analyses included chromVAR for transcription-factor motif accessibility, permutation-based false discovery rates for differential features, nucleosome-position inference from ATAC fragment sizes, pseudotime trajectory analysis, and epistasis scoring against an additive non-interaction model.
Limitations
- The paper states that future screens should target fewer cells per genotype (about 20) while expanding the number of genotypes, and it anticipates technological improvements to increase throughput and design complexity.
- The study is limited to two cell systems, GM12878 B lymphoblasts and primary human keratinocytes, so the generality of the inferred regulatory relationships to other cell types or tissues is not established in the text.
- Evident from the text: Perturb-ATAC measures chromatin accessibility and guide identity, not transcript or protein levels directly, so inferred transcription-factor activity and network relationships rely on accessibility readouts rather than direct expression measurements.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 27 cited sources checked · 0 supported · 0 flagged
- Findingown data
In primary human epidermal cells, Perturb-ATAC revealed three sequential modules of cis-elements that specify keratinocyte fate.
“Perturb-ATAC in primary human epidermal cells revealed three sequential modules of c/s-elements that specify keratinocyte fate.”
Quote in the paperSubstantial claim - Findingown data
SPI1 motif-containing sites (51,862 sites) exhibited a significant loss of accessibility in SPI1-targeted cells compared to NT cells (FDR < 1e-3).
“We found that SPI1 sites exhibited a significant loss of accessibility in SP/1-targeted cells compared to NT cells (FDR < 1e-3, permutation test; Methods), similar to bulk SP/1-targeting experiments (Figure 1G).”
Quote in the paperSubstantial claim - Findingown data
Cluster 2 included ncRNA 7SK and chromatin remodeler EZH2.
“Cluster 2 included the ncRNA 7SK, which represses enhancer transcription (Flynn et al., 2016), and the chromatin remodeler EZH2 (Figure 2F).”
Quote in the paperNot a substantial claim - Findingown data
Module 5 features included specific regulators of B cell development, such as IKZF1, BCL11A, EBF1, NFKB, MEF2C, and AP-1 factors.
“Module 4 contained homeobox domain TFs, and Module 5 features included specific regulators of B cell development, such as IKZF1 (also known as Ikaros), BCL11A, EBF1, NFKB, MEF2C and AP-1 factors.”
Quote in the paperNot a substantial claim - Findingcitation
Other altered TF motifs in SPI1-targeted cells included BCL11A, SPIB, and MEF2C, consistent with SPI1 function in regulating factors required for B cell lineage commitment.
“Other altered TF motifs in SPI1-targeted cells included BCL11A, SPIB, and MEF2C factors, consistent with the function of SPI1 in regulating factors required for B cell lineage commitment (Figure 2E and Table S3) (Su et al., 1996; Liu et al., 2003; Stehling-Sun et al., 2009).”
Quote in the paperNot a substantial claim
- Findingown data
Targeting ncRNA EBER2 identified 90 significantly altered features, including regions containing the PAX5 motif.
“Finally, targeting of the ncRNA EBER2 identified 90 significantly altered features, including regions containing the PAX5 motif, a factor that physically interacts with EBER2 to control gene expression (Lee et al., 2015).”
Quote in the paperNot a substantial claim - Findingown data
Depletion of IRF8 re-wired developmental features of Module 5, such that AP-1 factor activity was no longer coordinated with activity of IKZF1, RUNX, and MEF2C.
“For example, depletion of IRF8 re-wired the developmental features of Module 5, such that AP-1 factor activity was no longer coordinated with the activity of IKZF1, RUNX, and MEF2C (Figure 3D and S4C).”
Quote in the paperSubstantial claim - Findingown data
The most significant change in TF motif accessibility in SPI1-targeted cells was at SPI1-motif-containing regions (chromVAR accessibility loss 2.17, FDR < .0001).
“Similarly, the most significant change in TF motif accessibility in SP/1-targeted cells was at SPI1-motif-containing regions (chromVAR accessibility loss 2.17, FDR < .0001; Figure 2E).”
Quote in the paperSubstantial claim - Findingcitation
IRF8 depletion increased accessibility at IRF sites, consistent with its repressor activity.
“Consistent with reports of its repressor activity, IRF8 depletion increased accessibility at IRF sites (Tamura et al., 2008).”
Quote in the paperNot a substantial claim - Findingown data
Single-cell ATAC-seq reads recapitulated bulk ATAC-seq characteristics, including insert-size periodicity and fragment enrichment at transcription start sites.
“Single-cell ATAC-seq reads recapitulated characteristics of bulk ATAC-seq data, including insert-size periodicity and fragment enrichment at transcription start sites (Figure 1D).”
Quote in the paperSubstantial claim - Findingown data
ETS factors, which have roles in B cell development and immunological function, were highly correlated in Module 3.
“ETS factors, which have roles in B cell development and immunological function were highly correlated in Module 3.”
Quote in the paperNot a substantial claim - Findingown data
Depletion of EZH2 significantly increased accessibility at regions marked with H3K27me3 (chromVAR accessibility gain 0.78, FDR < .0001).
“Depletion of EZH2, a catalytic subunit of the Polycomb repressive complex 2 (PRC2), which deposits repressive H3K27me3 chromatin marks, significantly increased accessibility at regions marked with H3K27me3 (chromVAR accessibility gain 0.78, FDR <.0001; Figure 2E).”
Quote in the paperSubstantial claim - Findingown data
Perturb-ATAC was performed in 2,936 immortalized B lymphoblasts and 1,356 primary human keratinocytes, encompassing 63 genotype-phenotype relationships.
“We performed Perturb-ATAC in 2,936 immortalized B lymphoblasts and 1,356 primary human keratinocytes, encompassing 63 genotype-phenotype relationships.”
Quote in the paperSubstantial claim - Findingown data
Cluster 3 included EBER1, EBER2, TET2, and EBF1.
“Cluster 3 included the highly homologous ncRNAs, EBER1 and EBER2, as well as TET2 and EBF1.”
Quote in the paperNot a substantial claim - Findingown data
Feature correlations in NT cells identified five modules.
“We assessed feature correlations in NT cells and identified five modules (Figure 3B and S4A-B; Methods).”
Quote in the paperSubstantial claim- Rests on an assumption: Co-varying accessibility between sets of regions bound by two trans-factors reflects common regulation, and inverse correlation indicates one factor controls the activity or expression of a negative regulator of the other set.
- Findingown data
High-quality ATAC-seq profiles were obtained in 85.3% of cells in which GBCs were also detected.
“High quality ATAC-seq profiles were obtained in 85.3% of cells in which GBCs were also detected.”
Quote in the paperNot a substantial claim - Findingown data
Analysis of 40 single- and double-GBC genotypes revealed accessibility changes in 10,103 open chromatin sites (mean 404, range 0-2,250 per genotype) and 833 features (mean 23, range 0-110 per genotype).
“An analysis of ATAC-seq profiles derived from 40 single- and double-GBC genotypes (including NT controls) revealed accessibility changes in 10,103 open chromatin sites (mean: 404, range: 0–2,250 sites, per genotype) and 833 features (mean: 23, range: 0–110 features, per genotype; Figures 2F, S3A-C, Table S3).”
Quote in the paperSubstantial claim - Findingown data
Module 4 contained homeobox domain TFs.
“Module 4 contained homeobox domain TFs, and Module 5 features included specific regulators of B cell development, such as IKZF1 (also known as Ikaros), BCL11A, EBF1, NFKB, MEF2C and AP-1 factors.”
Quote in the paperNot a substantial claim - Findingown data
Regions containing JUND motifs were generally regulated by non-additive interactions (top 5% of all features).
“For example, regions containing TFAP2A motifs were generally regulated by additive interactions (bottom 5% of all features), while regions containing JUND motifs were generally regulated by non-additive interactions (top 5% of all features) (Figure 4D and 4E).”
Quote in the paperNot a substantial claim - Findingown data
Dual depletion of EZH2 and other factors de-repressed regions specifically active in alternate hematopoietic lineages.
“Indeed, depletion of EZH2 alone primarily de-repressed regions commonly marked by H3K27me3 across cell types which may not require additional targeting specificity, while dual depletion of EZH2 and other factors de-repressed regions specifically active in alternate hematopoietic lineages (Figures 4G and 4H).”
Quote in the paperSubstantial claim - Findingown data
Analysis of a CRISPRi screen in GM12878 lymphoblasts identified trans-factor control of several layers of epigenetic regulation.
“Analysis of a CRISPR-interference (CRISPRi) screen in GM12878 lymphoblasts identified trans-factor control of several layers of epigenetic regulation.”
Quote in the paperSubstantial claim - Findingown data
Regions containing TFAP2A motifs were generally regulated by additive interactions (bottom 5% of all features).
“For example, regions containing TFAP2A motifs were generally regulated by additive interactions (bottom 5% of all features), while regions containing JUND motifs were generally regulated by non-additive interactions (top 5% of all features) (Figure 4D and 4E).”
Quote in the paperNot a substantial claim - Findingown data
In cells expressing SPI1 sgRNAs, accessibility at the SPI1 promoter was lost compared to cells expressing NT sgRNAs.
“In cells expressing SPI1 sgRNAs, we observed a loss of accessibility at the promoter, compared to cells expressing NT sgRNAs (Figure 1E).”
Quote in the paperSubstantial claim - Findingown data
SPI1-targeted cells exhibited similar changes in accessibility across all peaks that were changed in bulk ATAC-seq experiments.
“More broadly, SP/1-targeted cells exhibited similar changes in accessibility across all peaks that were changed in bulk ATAC-seq experiments (Figure 1F).”
Quote in the paperSubstantial claim - Findingown data
The expanded Perturb-ATAC screen generated 40 sgRNA genotypes in 2,627 single cells from single- or dual-targeting of promoters of 12 trans-factors and 2 NT control sgRNAs.
“We generated 40 sgRNA genotypes in 2,627 single cells, derived from single- or dual-targeting of the promoters of 12 trans-factors and 2 NT control sgRNAs (Table S2).”
Quote in the paperSubstantial claim - Findingown data
Network reconstruction in perturbed cells highlighted the modules regulated by each perturbed factor.
“Network reconstruction in perturbed cells highlighted the modules regulated by each perturbed factor (Figures 3C-E).”
Quote in the paperSubstantial claim - Findingown data
Module 2 included chromatin regulators CTCF and CHD1.
“Module 2 included the chromatin regulators CTCF and CHD1.”
Quote in the paperNot a substantial claim - Findingown data
Clustering feature accessibility across all perturbations found three sub-clusters of trans-factors with correlated effects.
“We clustered feature accessibility across all perturbations and found three sub-clusters of trans-factors with correlated effects (Figure 2F).”
Quote in the paperNot a substantial claim - Findingown data
High-quality single-cell ATAC-seq profiles were obtained in 79.2% of cells in which GBCs were also detected.
“Next, we evaluated the quality of ATAC-seq reads; high quality single-cell ATAC-seq profiles were obtained in 79.2% of cells in which GBCs were also detected (Figure 1C).”
Quote in the paperSubstantial claim - Findingown data
DNMT3A depletion altered the coordinated activity of CTCF with other Module 2 factors, including SMAD5.
“DNMT3A depletion altered the coordinated activity of CTCF with other Module 2 factors, including SMAD5 (Figure 3E).”
Quote in the paperSubstantial claim - Findingown data
Module 1 features included factors broadly involved in hematopoietic development, such as SPI1 and IRF8.
“Module 1 features included factors broadly involved in hematopoietic development, such as SPI1 and IRF8.”
Quote in the paperNot a substantial claim - Findingown data
KLF4 and JUNB showed the second highest degree of synergy.
“KLF4 and JUNB, which exhibit the second greatest degree of synergy”
Quote in the paperNot a substantial claim - Findingown data
Among all targeted TF pairs, the fraction of synergistic interactions varied by more than three-fold.
“with a greater than three-fold variation in the proportion of synergistic interactions”
Quote in the paperNot a substantial claim - Findingown data
At their own target sites, JUNB and EHF showed no interaction.
“JUNB and EHF did not interact at their respective target sites”
Quote in the paperNot a substantial claim - Findingcitation
KLF4 and ZNF750 had a high degree of overlap in their target regions.
“KLF4 and ZNF750, which exhibited a high degree of target-region overlap”
Quote in the paperSubstantial claim - Findingown data
Expression correlation across tissues was linked to synergy between TFs.
“correlated gene expression was associated with synergy (Spearman’s correlation = 0.358)”
Quote in the paperSubstantial claim - Findingown data
Genes KRT78, DSG3, and HOPX were proximal to Module 2 regions.
“The genes KRT78, DSG3, and HOPX were proximal to Module 2 regions, representing programs of keratinization, cell-cell adhesion, and transcriptional regulation, respectively.”
Quote in the paperNot a substantial claim - Findingcitation
The 916 regions where synergy was seen for KLF4 and ZNF750 were commonly bound by both factors.
“these 916 regions were in fact commonly bound by both factors”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Boxer et al., 2014 source
Not checked in the free run.
- Findingown data
Globally, ZNF750 knockout resulted in a nearly even total of 649 gained and 620 lost peaks (FDR < 0.01, FC>1).
“Globally, ZNF750 knockout resulted in a nearly even total of 649 gained and 620 lost peaks (FDR < 0.01, FC>1).”
Quote in the paperNot a substantial claim - Findingown data
Closer analysis of selected TFs confirmed patterns of dynamic accessibility matching their module.
“Closer analysis of these TFs confirmed patterns of dynamic accessibility matching their module (Figure 5E).”
Quote in the paperNot a substantial claim - Findingown data
An average of 87.9% of reads mapped to an sgRNA.
“An average of 87.9% of reads mapped to an sgRNA (Figure S6C).”
Quote in the paperNot a substantial claim - Findingown data
Perturbing CEBPA decreased accessibility of TP63 and NFκB features.
“In contrast, perturbing CEBPA decreased accessibility of TP63 and NFκB features.”
Quote in the paperSubstantial claim - Findingown data
Perturb-ATAC obtains perturbation and ATAC-seq measurements together in single cells.
“achieving simultaneous measurements of perturbations and ATAC-seq profiles in single cells”
Quote in the paperSubstantial claim - Findingown data
EHF and ZNF750 displayed high synergy.
“the high synergy observed for EHF and ZNF750”
Quote in the paperNot a substantial claim - Findingown data
There was a weak correlation between the magnitude of single perturbation and the degree of genetic interaction for that feature.
“Unlike in other systems, we observed a weak correlation between the magnitude of single perturbation and the degree of genetic interaction for that feature (Costanzo et al., 2010) (Figure S7E).”
Quote in the paperNot a substantial claim - Findingown data
Analysis of perturbed factors and their target regions uncovered an interconnected network of regulation.
“An analysis of the perturbed factors and their target regions uncovered an inter-connected network of regulation (Figure 6E).”
Quote in the paperSubstantial claim - Findingown data
CEBPA knockout cells were biased toward an early differentiation state.
“This analysis revealed a role for CEBPA in initiating differentiation, as CEBPA knockout cells were biased toward an early differentiation state.”
Quote in the paperSubstantial claim - Findingown data
Genes proximal to Module 1 regions included AURKB and COL11A1.
“Genes proximal to Module 1 regions included AURKB, a regulator of mitosis, and COL11A1, a component of the basement membrane.”
Quote in the paperNot a substantial claim - Findingown data
EHF and JUNB displayed comparatively low synergy.
“EHF and JUNB had relatively low synergy”
Quote in the paperNot a substantial claim - Findingcitation
Placement of each cell along a pseudotime trajectory highlighted the continuous nature of differentiation.
“Placement of each cell along a pseudotime trajectory highlighted the continuous nature of differentiation (Figure 5B) (Qiu et al., 2017).”
Quote in the paperNot a substantial claim - Findingown data
399 features were altered across TF knockout cells (FDR < 0.1).
“We identified 399 features altered across TF knockout cells (FDR < 0.1).”
Quote in the paperSubstantial claim - Findingown data
These features included multiple instances of TFs autoregulating their target sites.
“These features included multiple instances of TFs autoregulating their target sites (Figure 6C, Table S6).”
Quote in the paperNot a substantial claim - Findingown data
In keratinocyte differentiation, loss of JUNB raised accessibility at sites containing the CEBP motif.
“JUNB knockout increased accessibility of CEBP motif sites”
Quote in the paperSubstantial claim - Findingown data
When both EHF and JUNB were knocked out, TP63 accessibility rose much more than expected from the individual knockouts.
“with dual EHF and JUNB knockout cells increasing TP63 accessibility far more than would be predicted from the single knockouts”
Quote in the paperSubstantial claim - Findingown data
Pairs of factors with the most synergistic interactions also had greater overlap of their target sites.
“the factor pairs with the highest prevalence of synergistic interactions exhibited greater overlap of target sites”
Quote in the paperSubstantial claim - Findingown data
Module 2 (12 features, including CEBP, KLF, and ZNF750) exhibited high accessibility specifically during mid-differentiation.
“Module 2 (12 features, including CEBP, KLF, and ZNF750), exhibited high accessibility specifically during mid-differentiation. (Figure 5B).”
Quote in the paperNot a substantial claim - Findingown data
Module 2 factors displayed diverging roles in differentiation.
“Module 2 factors, which had highest accessibility mid-differentiation, displayed diverging roles in differentiation.”
Quote in the paperNot a substantial claim - Findingown data
Combined loss of EHF and JUNB produced only a modest change in accessibility at CEBP motif sites.
“while the dual EHF and JUNB knockout had a modest effect”
Quote in the paperSubstantial claim - Findingown data
Module 1 (30 features, including AP-1 and NFκB) had high accessibility in progenitor cells which decreased in differentiation.
“The first module (30 features, including AP-1 and NFκB) had high accessibility in progenitor cells which decreased in differentiation.”
Quote in the paperNot a substantial claim - Findingown data
Perturbation of ZNF750 increased accessibility at TP63 and NFκB motif sites.
“For example, perturbation of ZNF750 increased accessibility at TP63 and NFκB motif sites, two factors known to regulate epidermal identity (Yang et al., 2011).”
Quote in the paperNot a substantial claim - Findingown data
Associated genes included KLK6 and SERPINA12, a protease and protease-inhibitor.
“Associated genes included KLK6 and SERPINA12, a protease and protease-inhibitor, respectively, which regulate coordinated desquamation of cells from the epidermis.”
Quote in the paperNot a substantial claim - Findingown data
KLF4 knockout cells shifted towards a later differentiation state.
“In contrast, KLF4 knockout cells shifted towards a later differentiation state.”
Quote in the paperSubstantial claim - Findingown data
Hierarchical clustering of dynamic features across keratinocyte differentiation produced three major clusters, called modules.
“The matrix of these features vs. Cells (arranged by increasing pseudotime) was hierarchically clustered using the heatmap.2 function in the gplots R package, resulting in three major clusters (referred to as modules).”
Quote in the paperSubstantial claim - Findingown data
In permutation testing of SPI1 motif accessibility, neither bulk-ATAC nor Perturb-ATAC produced any permuted trial as extreme as the observed unpermuted result.
“In this analysis, for both bulk-ATAC and Perturb-ATAC, no trial yielded a result as extreme as the result observed in the unpermuted sample.”
Quote in the paperSubstantial claim - Study design and conductnone given
Perturb-ATAC combines multiplexed CRISPR interference or knockout with genome-wide chromatin accessibility profiling in single cells by detecting CRISPR guide RNAs and open chromatin sites together using ATAC-seq.
“Here we present Perturb-ATAC, a method which combines multiplexed CRISPR interference or knockout with genome-wide chromatin accessibility profiling in single cells, based on the simultaneous detection of CRISPR guide RNAs and open chromatin sites by assay of transposase-accessible chromatin with sequencing (ATAC-seq).”
Quote in the paperSubstantial claim- Rests on an assumption: Epigenetic assays require large amounts of cellular material and are difficult to couple with genetic perturbations at scale.
- Rests on an assumption: Most studies are limited to measuring how single genetic perturbations affect chromatin state in bulk cell populations.
- Study design and conductown data
Cells processed across several microfluidic chips exhibited no noticeable chip bias in ATAC-seq signal.
“Cells processed across several microfluidic chips exhibited no noticeable chip bias in ATAC-seq signal (Figure S2E).”
Quote in the paperNot a substantial claim - Study design and conductnone given
Perturb-ATAC measures CRISPR sgRNA sequences and ATAC-seq profiles in single cells.
“This method, termed perturbation-indexed single-cell ATAC-seq (Perturb-ATAC), measures CRISPR sgRNA sequences and ATAC-seq profiles in single cells.”
Quote in the paperSubstantial claim- Rests on an assumption: Epigenetic assays require large amounts of cellular material and are difficult to couple with genetic perturbations at scale.
- Rests on an assumption: Most studies are limited to measuring how single genetic perturbations affect chromatin state in bulk cell populations.
- Interpretationown data
Depletion of either NFKB1 or RELA resulted in a stable nucleosome structure surrounding regions that gained accessibility, suggesting these factors influence binding of co-factors in an independently established nucleosome-free region.
“Depletion of either NFKB1 or RELA resulted in a stable nucleosome structure surrounding regions that gained accessibility, suggesting that these factors influence the binding of co-factors in an independently-established nucleosome-free región (Figure S3F).”
Quote in the paperNot a substantial claim - Premisecitation
High-throughput genetic screens can be coupled with simultaneous transcriptome phenotyping in single cells.
“Similar advances in the ability to measure transcriptomes in single cells have recently allowed high-throughput genetic screens coupled with simultaneous transcriptome phenotyping (Dixit et al., 2016; Adamson et al., 2016; Jaitin et al., 2016; Datlinger et al., 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
IRF8 regulates the expression and activity of IKZF1 in pre-B cells.
“Indeed, IRF8 regulates the expression and activity of IKZF1 in pre-B cells (Ma et al., 2008; Pang et al., 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ma et al., 2008
Not checked in the free run.
- cites Pang et al., 2016 source
Not checked in the free run.
- Interpretationown data
GBC detection does not interfere with the generation of ATAC-seq libraries in single cells.
“These results indicate that GBC detection does not interfere with the generation of ATAC-seq libraries in single cells.”
Quote in the paperSubstantial claim - Interpretationown data
Perturb-ATAC identifies epigenomic phenotypes associated with perturbations of diverse categories of trans-factors.
“These results demonstrate that Perturb-ATAC identifies epigenomic phenotypes associated with perturbations of diverse categories of trans-factors.”
Quote in the paperSubstantial claim - Interpretationown data
EBF1 cooperated with EZH2 to repress alternate monocyte and natural killer cell fate.
“For example, EBF1 cooperated with EZH2 to repress alternate monocyte and natural killer cell fate, while IRF8 and RELA cooperated with EZH2 to repress progenitor fates (Figure 4H).”
Quote in the paperSubstantial claim - Interpretationown data
Cluster 1 included IRF8, RELA, BRG1, and DNMT3A, suggesting these factors may cooperate to establish the B cell chromatin landscape.
“Cluster 1 included the B cell lineage-determining TFs IRF8 and RELA, and the chromatin regulators BRG1 and DNMT3A, suggesting that these factors may cooperate to establish the B cell chromatin landscape (Corces et al., 2016; Lara-Astiaso et al., 2014).”
Quote in the paperSubstantial claim - Interpretationown data
In cells depleted of both EBF1 and SPI1, observed accessibility matched expected accessibility based on the combined effect of each factor alone, suggesting these factors do not interact.
“In cells depleted of both EBF1 and SPI1, the observed accessibility matched the expected accessibility based on the combined effect of each factor alone, suggesting that these factors do not interact.”
Quote in the paperSubstantial claim - Interpretationown data
Perturb-ATAC simultaneously measures GBC sequences and ATAC-seq data in single cells with high fidelity.
“Altogether, these findings demonstrate that Perturb-ATAC simultaneously measures GBC sequences and ATAC-seq data in single cells with high fidelity.”
Quote in the paperSubstantial claim - Interpretationcitation
Depletion of EBER2 altered interactions between AP-1, IRF, and NFKB, possibly through viral RNA binding and activation of viral sensors.
“Finally, depletion of EBER2 altered interactions between AP-1, IRF, and NFKB, possibly through viral RNA binding and activation of viral sensors (Figure S4F) (Samanta et al., 2006).”
Quote in the paperNot a substantial claim - Interpretationown data
IRF8 and RELA cooperated with EZH2 to repress progenitor fates.
“For example, EBF1 cooperated with EZH2 to repress alternate monocyte and natural killer cell fate, while IRF8 and RELA cooperated with EZH2 to repress progenitor fates (Figure 4H).”
Quote in the paperSubstantial claim - Interpretationown data
Co-binding is the basis of epistatic interaction.
“providing strong support for the model that co-binding underlies epistatic interaction”
Quote in the paperSubstantial claim - Interpretationown data
Perturb-ATAC uncovers epistatic interactions relevant to development and disease.
“Although perturbation of NFKB1 did not alter many other variant-enhancers in isolation, dual perturbation of NFKB1 and other factors modulated accessibility associated with several diseases, demonstrating that Perturb-ATAC uncovers epistatic interactions relevant to development and disease (Figure 4J).”
Quote in the paperSubstantial claim - Interpretationown data
The absence of interaction between JUNB and EHF at their target sites points to an indirect mechanism.
“suggesting an indirect effect”
Quote in the paperNot a substantial claim - Study design and conductnone given
The workflow yielded many more double-targeted cells than expected from the observed doublet rate (~2.9%).
“This workflow resulted in far more double-targeted cells than would be observed solely from the observed doublet rate calculated from the appearance of double GBC-expressing cells in our initial single-targeting experiment (~ 2.9%).”
Quote in the paperSubstantial claim - Study design and conductown data
We determined a minimum target cell number empirically by down-sampling from a larger pool and comparing accessibility profiles.
“We empirically determined a target minimum cell number required for analysis by down-sampling cells from a larger pool and comparing accessibility profiles.”
Quote in the paperSubstantial claim - Premisecitation
Prior work has shown that pooling five or more cells accurately reproduces chromatin accessibility profiles.
“previous reports have shown that aggregation of five or more cells is sufficient toaccurately reproduce chromatin accessibility profiles (Satpathy et al., 2018; Schep et al., 2017).”
Quote in the paperSubstantial claim0 of 2 sources checked - Study design and conductown data
Most five-cell samples correlated strongly (r > 0.8) with bulk ATAC-seq profiles.
“This analysis indicated that the vast majority of samples of five cells were highly correlated (r > 0.8) with a bulk ATAC-seq profile.”
Quote in the paperSubstantial claim
- May combine two claims. 51
- Classified as probably not a substantial claim. 25
- The quote only partly states this claim. 2
May combine two claims.
Findingown dataPerturb-ATAC was applied to transcription factors, chromatin-modifying factors, and noncoding RNAs in about 4,300 single cells, covering more than 63 genotype-phenotype relationships.
“We applied Perturb-ATAC to transcription factors (TFs), chromatin-modifying factors, and noncoding RNAs (ncRNAs) in ~4,300 single cells, encompassing more than 63 genotype-phenotype relationships.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn human B lymphocytes, Perturb-ATAC identified regulators of chromatin accessibility, TF occupancy, and nucleosome positioning, and a hierarchy of TFs governing B cell state, variation, and disease-associated cis-regulatory elements.
“Perturb-ATAC in human B lymphocytes uncovered regulators of chromatin accessibility, TF occupancy, and nucleosome positioning, and identified a hierarchy of TFs that govern B cell state, variation, and disease-associated c/s-regulatory elements.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationNFKB1 and RELA showed overlapping and distinct effects, in line with prior studies demonstrating differences in NFκB subunit binding patterns.
“Interestingly, two NFκB subunits, NFKB1 and RELA, showed overlapping and distinct effects, in line with prior studies demonstrating differences in the binding patterns of NFκB subunits through the formation of distinct protein complexes (Figures 2F and S3B; Zhao et al., 2014).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataLoss of either EBER1 or EBER2 altered accessibility at EBF1 sites, consistent with these factors acting in the same pathway.
“and loss of either factor altered accessibility at EBF1 sites, consistent with these factors acting in the same pathway (Figure S3B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDepletion of EBF1 resulted in altered correlation of Module 2, as well as its own Module 5.
“For example, depletion of EBF1 resulted in altered correlation of Module 2, as well as its own Module 5.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDepletion of either EBER1 or TET2 alone did not affect accessibility at IKZF1 binding sites, while dual depletion resulted in an unexpected increase in accessibility.
“Conversely, depletion of either EBER1 or TET2 alone did not affect accessibility at IKZF1 binding sites, while dual depletion resulted in an unexpected increase in accessibility (Figure 4B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataReads were almost exclusively assigned to one GBC, and multiple GBCs were detected in only 9 of 309 cells.
“As expected, reads were almost exclusively assigned to one GBC (NT1, NT2, or SPI1); multiple GBCs were only detected in 9/309 cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDepletion of EZH2 alone primarily de-repressed regions commonly marked by H3K27me3 across cell types, which may not require additional targeting specificity.
“Indeed, depletion of EZH2 alone primarily de-repressed regions commonly marked by H3K27me3 across cell types which may not require additional targeting specificity, while dual depletion of EZH2 and other factors de-repressed regions specifically active in alternate hematopoietic lineages (Figures 4G and 4H).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCells passing filter yielded an average of 11.33 × 10^3 fragments mapping to the nuclear genome, and approximately 43.05% of reads were within bulk ATAC-seq peaks.
“Cells passing filter yielded an average of 11.33 × 103 fragments mapping to the nuclear genome, and approximately 43.05% of reads were within bulk ATAC-seq peaks, similar to previously published scATAC-seq as well as high-quality bulk ATAC-seq datasets (Buenrostro et al., 2015; Corces et al., 2017) (Figure 1C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNFKB1 and RELA exhibited distinct effects on Module 5, while altering Module 4 to a similar extent.
“The two NFκB subunits, NFKB1 and RELA, exhibited distinct effects on Module 5, which includes NFKB1 and RELA, while altering Module 4 to a similar extent (Figures 3H, S4E).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSingle-cell ATAC-seq in primary human epidermal cells identified three regulatory modules in keratinocyte differentiation, and a Perturb-ATAC CRISPR-deletion screen revealed key TF regulators of each module.
“scATAC-seq in primary human epidermal cells identified three regulatory modules in keratinocyte differentiation, and a Perturb-ATAC CRISPR-deletion screen revealed key TF regulators of each module.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSPI1 motif sites were unchanged in EBF1-depleted cells, while depletion of SPI1 strongly decreased accessibility of these sites.
“For example, SPI1 motif sites were unchanged in EBF1 depleted cells, while depletion of SPI1 strongly decreased the accessibility of these sites (Figure 4B).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe 12 targeted trans-factors included transcription factors EBF1, IRF8, NFKB1, RELA, and SPI1; chromatin modifiers BRG1, DNMT3A, EZH2, and TET2; and noncoding RNAs 7SK, EBER1, and EBER2.
“The 12 targeted trans-factors included transcription factors (EBF1, IRF8, NFKB1, RELA, and SPI1), chromatin modifiers (BRG1, DNMT3A, EZH2, and TET2), and noncoding RNAs (7SK, EBER1, and EBER2) that have previously been shown to impact normal and neoplastic B cell development and function (Nutt and Kee, 2007; Lunning and Green, 2015).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCells passing filter yielded an average of 10.68 × 10^3 fragments mapping to the nuclear genome, and approximately 43.85% of reads were within peaks present in bulk profiles.
“Cells passing filter yielded an average of 10.68 × 103 fragments mapping to the nuclear genome, and approximately 43.85% of reads were within peaks present in bulk profiles (Figure 2C).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationSub-nucleosome-sized fragments were enriched at the CTCF motif, indicating a central nucleosome-free region; nucleosome-sized fragments were enriched upstream and downstream, representing the +1 and −1 nucleosomes.
“As expected, sub-nucleosome fragments were enriched at the CTCF motif, indicating a central nucleosome-free region. In contrast, nucleosome-sized fragments were enriched upstream and downstream relative to the CTCF motif, representing the +1 and −1 nucleosomes (Vierstra et al., 2014).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataModule 3 (25 features) included target regions of ETS and IRF family factors and gained accessibility in late differentiation.
“Finally, Module 3 (25 features) included target regions of ETS and IRF family factors, and gained accessibility in late differentiation.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationZNF750 target regions were not uniformly more or less accessible in ZNF750-targeted cells, consistent with its role as a positive and negative gene regulator.
“Notably, ZNF750 target regions were not uniformly more or less accessible in ZNF750-targeted cells, consistent with the role of this factor as a positive and negative gene regulator (Boxer et al., 2014).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCells largely separated by differentiation time point, but a few precocious differentiating cells were observed in the Day 0 population, and some Day 6 cells remained in a mid-differentiation state.
“While cells largely separated by their differentiation time point, a few “precocious” differentiating cells were observed in the Day 0 population, and some Day 6 cells remained in a mid-differentiation state (Figure 5B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAlthough perturbation of NFKB1 did not alter many other variant-enhancers in isolation, dual perturbation of NFKB1 and other factors modulated accessibility associated with several diseases.
“Although perturbation of NFKB1 did not alter many other variant-enhancers in isolation, dual perturbation of NFKB1 and other factors modulated accessibility associated with several diseases, demonstrating that Perturb-ATAC uncovers epistatic interactions relevant to development and disease (Figure 4J).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data67 TFs with dynamic accessibility in differentiation clustered into three modules.
“We identified 67 TFs with dynamic accessibility in differentiation, which clustered into three modules (Figures 5C and 5D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNFκB binding sites were enriched near causal variants associated with multiple sclerosis and systemic lupus erythematosus, and these sites demonstrated altered accessibility in cells where NFKB1 or RELA were depleted.
“NFκB binding sites were shown to be enriched near causal variants associated with multiple sclerosis and system lupus erythematosus (Farh et al., 2015), and these sites demonstrated altered accessibility in cells where NFKB1 or RELA were depleted (Figure 4J).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe dual-knockout workflow identified 344 additive relationships, 102 synergistic interactions, and 101 buffering interactions.
“This workflow identified 344 additive relationships, 102 synergistic interactions, and 101 buffering interactions.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data279 single sgRNA-expressing cells and 235 double sgRNA-expressing cells were identified, encompassing 23 distinct genotypes of all expected individual and double CRISPR perturbations.
“Altogether, weidentified 279 single sgRNA-expressing cells and 235 double sgRNA-expressing cells, encompassing 23 distinct genotypes of all expected individual and doublé CRISPR perturbations (Figure 6B, Table S5).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPerturb-ATAC data permitted analysis of three levels of chromatin regulation: individual cis-regulatory elements, inferred transcription factor activity from cis-regulatory modules, and nucleosome occupancy and positioning.
“Analysis of Perturb-ATAC data enabled the study of several layers of chromatin regulation: 1) individual c/s-regulatory elements, 2) inferred TF activity from cis-regulatory modules, and 3) nucleosome positioning and occupancy.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ZNF750-bound enhancer of SPRR2E lost accessibility upon ZNF750 disruption, while other ZNF750 binding sites gained accessibility.
“For example, the ZNF750-bound enhancer of the epidermal cornified envelope gene SPRR2E lost accessibility upon ZNF750 disruption, while other ZNF750 binding sites gained accessibility (Figure 6D and S7A).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAfter filtering for features significantly altered in at least one genotype and removing redundant annotations, 390 motif/ChIP features remained for correlation analysis.
“Only features that were significantly altered in at least one genotype were considered, and redundant annotations were removed, resulting in 390 motif/ChIP feature annotations for analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationATAC-seq informs the identification of enhancers, nucleosome positioning, and inference of transcription factor binding.
“This method informs the identification of enhancers, the positioning of nucleosomes, and the inference of transcription factor binding (Buenrostro et al., 2013; Schep et al., 2015, 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Buenrostro et al., 2013 source
Not checked in the free run.
- cites Schep et al., 2015, 2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataCombinatorial deletion of all pairs of these TFs uncovered epistatic relationships and highlighted genomic co-localization as a basis for synergistic interactions.
“Combinatorial deletion of all pairs of these TFs uncovered their epistatic relationships and highlighted genomic co-localization as a basis for synergistic interactions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationATAC-seq uses a hyperactive Tn5 transposase to measure the activity of regulatory DNA elements.
“We recently developed the assay for transposase-accessible chromatin with sequencing (ATAC-seq), which utilizes a hyperactive transposase (Tn5) to measure the activity of regulatory DNA elements (Buenrostro et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Buenrostro et al., 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationATAC-seq can be performed in single cells, revealing cell-to-cell variability and rare epigenomic phenotypes.
“Importantly, ATAC-seq can be performed in single cells (scATAC-seq), uncovering cell-to-cell variability and rare epigenomic phenotypes (Cusanovich et al., 2018; Satpathy et al., 2018; Buenrostro et al., 2018).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataPerturb-ATAC consistently detects GBCs with high confidence and a low false positive rate.
“These results demonstrate that Perturb-ATAC consistently detects GBCs with high confidence and a low false positive rate (Figures 1B, S1B and S1C).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataLoss of co-variation is not dependent on altered accessibility of each factor, decoupling two mechanisms of TF activity.
“Of note, the loss of co-variation is not dependent on altered accessibility of each factor, decoupling two mechanisms of TF activity (Figures 3E and S4D).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationSingle-cell ATAC-seq profiles can be paired with orthogonal measurements of RNA or protein expression in the same cell.
“Additionally, scATAC-seq profiles can be paired with orthogonal measurements of RNA or protein expression in the same cell (Satpathy et al., 2018; Chen et al., 2018a).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Satpathy et al., 2018 source
Not checked in the free run.
- cites Chen et al., 2018a
Not checked in the free run.
May combine two claims.
Interpretationown dataRegions losing accessibility upon depletion of 7SK exhibited stronger central nucleosome structure in 7SK-depleted cells, possibly indicating that 7SK interacts with nucleosome remodeling factors.
“Reflecting another distinct mechanism, regions losing accessibility upon depletion of 7SK exhibited stronger central nucleosome structure in 7SK-depleted cells, possibly indicating that 7SK interacts with nucleosome remodeling factors, as has been shown for the BAF complex (Figure S3F; Flynn et al.,”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataMultiplexed perturbations mapped epistatic relationships between TFs, and genomic co-localization and co-expression of TFs may predict genetic interaction.
“We mapped epistatic relationships between TFs using multiplexed perturbations and suggest that genomic co-localization and co-expression of TFs may predict genetic interaction.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataSPI1 depletion increased accessibility of IRF motif regions, demonstrating that SPI1 exhibits activating and repressive functions.
“In contrast, SPI depletion increased accessibility of IRF motif regions, demonstrating that SPI1 exhibits activating and repressive functions, as has been reported (van Riel and Rosenbauer, 2014).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTrans-factors regulate nucleosome positioning in distinct ways, and Perturb-ATAC can read out nucleosome structure changes associated with perturbations.
“Overall, these results demonstrate that trans-factors regulate nucleosome positioning in distinct ways and that Perturb-ATAC can read out nucleosome structure changes associated with perturbations.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataRare ATAC-seq reads mapping to the viral construct did not influence ATAC-seq profiles, and observed accessibility at potential sgRNA mismatch loci indicated no evidence of off-target repression.
“Rare ATAC-seq reads mapping to the viral construct did not appear to influence ATAC-seq profiles, and observed accessibility at potential sgRNA mismatch loci indicated no evidence of off-target repression (Methods, Figure S2D).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationPackaging steps were performed in separate cultures to eliminate the likelihood of recombination of sgRNAs and GBCs between vectors.
“To eliminate the likelihood of recombination of sgRNAs and GBCs between vectors, as has been recently described (Adamson et al., 2018; Feldman et al., 2018; Hill et al., 2018; Xie et al., 2018), we performed packaging steps in separate cultures.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe correlation between IKZF1 and FOS:JUN in NT cells (r = 0.420, p = 5.60e-6) was lost in IRF8-depleted cells (r = -0.051, p = 0.627), suggesting IRF8 coordinates these two factors.
“In particular, the correlation between IKZF1 and FOS:JUN (AP-1) in NT cells (r = 0.420, p = 5.60e-6) was lost in IRF8 depleted cells (r = - 0.051, p=0.627), suggesting that IRF8 coordinates these two factors (Figures 3F and 3G).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenCo-varying accessibility between sets of regions bound by two trans-factors may reflect common regulation, whereas inverse correlation may indicate that one factor controls the activity or expression of a negative regulator of the other set of regions.
“For example, co-varying accessibility between sets of regions bound by two trans-factors may reflect common regulation. In contrast, inverse correlation may indicate that one factor controls the activity or expression of a negative regulator of the other set of regions.”
Quote in the paperSubstantial claim- Rests on an assumption: Co-varying accessibility between sets of regions bound by two trans-factors reflects common regulation, and inverse correlation indicates one factor controls the activity or expression of a negative regulator of the other set.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenCRISPRi guide RNAs were designed to maximize knockdown efficiency and minimize off-target effects.
“CRISPRi guide RNAs were designed to maximize knockdown efficiency and minimize off-target effects (Figure S2A-C, Table S1).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataRegions that gained accessibility in DNMT3A-depleted cells exhibited a stronger central nucleosome, consistent with a model in which DNMT3A recruits negative regulatory factors to an open chromatin region.
“However, regions that gained accessibility in DNMT3A-depleted cells exhibited a stronger central nucleosome, consistent with a model in which DMNT3A recruits negative regulatory factors to an open chromatin region.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataRegions marked by H3K27me3 exhibited a high degree of interaction, particularly involving EZH2, suggesting other factors may guide EZH2 recruitment or activity.
“Similarly, regions marked by the repressive histone modification H3K27me3 exhibited a high degree of interaction, particularly involving EZH2, suggesting that other factors may guide EZH2 recruitment or activity (Figure 4F).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataStringent cutoffs were used to assign the presence or absence of a GBC.
“We used stringent cutoffs to assign the presence or absence of a GBC (Figure S1B).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCEBPA has a known role in murine epidermis.
“We chose three Module 2 regulators: 1) KLF4, which induces epidermal differentiation genes, 2) ZNF750, a factor engaged in positive and negative gene regulation in epidermal differentiation, and 3) CEBPA, which has known role in murine epidermis (Lopez et al., 2009; Sen et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationKLF4 induces epidermal differentiation genes.
“We chose three Module 2 regulators: 1) KLF4, which induces epidermal differentiation genes, 2) ZNF750, a factor engaged in positive and negative gene regulation in epidermal differentiation, and 3) CEBPA, which has known role in murine epidermis (Lopez et al., 2009; Sen et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationJUNB, an AP-1 family member, controls epidermal homeostasis and tumorigenesis.
“For a candidate Module 1 regulator, we selected JUNB, an AP-1 family member which controls epidermal homeostasis and tumorigenesis (Eckert et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Eckert et al., 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenGuides were designed with CRISPOR and selected to reduce genomic loci with 0-4 mismatches, aiming to limit off-target CRISPRi activity.
“Guides were designed using the CRISPOR online tool (http://crispor.tefor.net/) and chosen to minimize the number of genomic loci with 0–4 mismatches, with the intention of minimizing the chance for any off-target CRISPRi activity.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationThe human epidermis is a constantly renewing stratified epithelial tissue, and thousands of genes change in expression during terminal epidermal differentiation as progenitor cells migrate from the basal layer, begin keratinization, and undergo cornification.
“The human epidermis is a constantly renewing stratified epithelial tissue, and thousands of genes change in expression during terminal epidermal differentiation as progenitor cells migrate from the basal layer, begin keratinization, and undergo cornification to form the outer layer of the skin. (Lopez-Pajares et al., 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lopez-Pajares et al., 2015 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe study identified both regulatory factors responsible for distinct epidermal states and rerouted differentiation trajectories in response to TF perturbation.
“Together, we identified both the regulatory factors responsible for distinct epidermal states as well as rerouted differentiation trajectories in response to TF perturbation.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataCells with high background reads (greater than 1%) were excluded, and remaining cells clearly separated into single or double sgRNA-expressing populations.
“Cells with high background reads (greater than 1%) were excluded, and the remaining cells clearly separated into single or double sgRNA-expressing populations (Figure S6D-F).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningCEBPA knockout cells lost accessibility of Module 2 features but gained Module 1 accessibility, indicating they were unable to fully engage the mid-differentiation program.
“Correspondingly, CEBPA knockout cells lost accessibility of Module 2 features but gained Module 1 accessibility, indicating that CEBPA knockout cells were unable to fully engage the mid-differentiation program.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEHF is an ETS factor implicated in controlling epidermal differentiation.
“As a Module 3 regulator, we chose EHF, an ETS factor implicated in controlling epidermal differentiation (Rubin et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rubin et al., 2017 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductown dataA second Perturb-ATAC protocol was developed to directly detect sgRNA rather than a GBC and to assess CRISPR gene knockouts rather than CRISPR interference.
“We developed a second Perturb-ATAC protocol to achieve two goals: 1) to directly detect the sgRNA rather than a GBC, and 2) to assess CRISPR gene knockouts rather than CRISPR interference.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTP63 serves as a key regulator of epidermal homeostasis and differentiation.
“TP63, a master regulator of epidermal homeostasis and differentiation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bao et al., 2015 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Study design and conductnone givenAll samples had consent obtained under the NIH genomic data sharing policy.
“Consent for all samples were obtained in accordance with the NIH genomic data sharing policy.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Interpretationown dataEHF and JUNB act antagonistically in controlling accessibility at CEBP motif sites.
“reflecting a negative interaction between EHF and JUNB”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataGene expression knockdown was confirmed using qRT-PCR.
“gene expression knockdown was confirmed using the Agilent Brilliant II qRT-PCR 1-Step kit.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningPerturb-ATAC is a high-throughput platform linking genotypes to epigenetic phenotypes and can reveal molecular mechanisms that control cell fate and function through chromatin state changes.
“Perturb-ATAC provides a high-throughput platform to link genotypes with epigenetic phenotypes iand ultimately reveal molecular mechanisms that govern cell fate and function through modulation of the chromatin state.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll plasmid sgRNA and GBC sequences were verified by Sanger sequencing.
“The sgRNA sequences and GBC sequences of all plasmids were confirmed by Sanger sequencing.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationZNF750 is engaged in positive and negative gene regulation in epidermal differentiation.
“We chose three Module 2 regulators: 1) KLF4, which induces epidermal differentiation genes, 2) ZNF750, a factor engaged in positive and negative gene regulation in epidermal differentiation, and 3) CEBPA, which has known role in murine epidermis (Lopez et al., 2009; Sen et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenqRT-PCR was run in duplicate, and each sample's expression values were normalized to 18S.
“qRT-PCR was performed in duplicate, and expression values for each sample were normalized against 18S.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningFor epistasis interaction categorization, the null distribution was generated separately for each feature to account for differences in scale and variability.
“This procedure was performed separately for each feature to account for differences in scale and variability across features.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenCas9 nuclease activity was tested by PCR amplification of ~800bp cDNA fragments around sgRNA binding sites followed by Sanger sequencing.
“Cas9 nuclease activity was assessed by PCR amplifying ~800bp fragments of cDNA surrounding sgRNA binding sites and analyzing the resulting fragments by Sanger sequencing”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenCells with more than 1% background-associated reads were removed from analysis.
“Cells with greater than 1% of reads associated with background were excluded from analysis.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationThe keratinocyte feature deviation matrix was processed to remove plate and experiment batch effects.
“The feature deviation matrix including unperturbed and CRISPR knockout cells was first processed using Seruat 2.0.1 (Butler et al., 2018) to regress out plate andexperiment batch effects.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Butler et al., 2018 source
Not checked in the free run.
May combine two claims.
Study design and conductown dataATAC reads matching the CRISPR viral construct were very rare (median 0.0049%), and the abundance of such reads did not appear to affect epigenomic profiles.
“We observed an extremely low rate of ATAC reads matching the CRISPR viral construct (median 0.0049%) and found no evidence of the abundance of CRISPR construct matching reads influencing epigenomic profiles.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown data38/40 GM12878 genotypes and 23/23 keratinocyte genotypes had more than five cells.
“indeed 38/40 genotypes for GM12878 cells and 23/23 genotypes for keratinocytes consist of greater than five cells.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Epigenetic assays require large amounts of cellular material and are difficult to couple with genetic perturbations at scale.
“However, it is challenging to characterize each trans-factor or c/s-element, since epigenetic assays require large amounts of cellular material and are difficult to couple with genetic perturbations at scale.”
The paper relies on this without support.
Most studies are limited to measuring how single genetic perturbations affect chromatin state in bulk cell populations.
“Therefore, most studies are limited to measuring how single genetic perturbations affect chromatin state in bulk cell populations.”
The paper relies on this without support.
Co-varying accessibility between sets of regions bound by two trans-factors reflects common regulation, and inverse correlation indicates one factor controls the activity or expression of a negative regulator of the other set.
“For example, co-varying accessibility between sets of regions bound by two trans-factors may reflect common regulation. In contrast, inverse correlation may indicate that one factor controls the activity or expression of a negative regulator of the other set of regions.”
The paper relies on this without support.
Previous high-throughput genetic screens have mostly introduced genetic variants into cell populations and then selected for a narrow set of phenotypes.
“Previous high-throughput genetic screens have largely relied on the introduction of genetic variants in a population of cells (for example, using CRISPR/Cas9), followed by the selection of cells containing variants that confer a limited set of cellular phenotypes, such as increased cell growth or viability.”
The paper relies on this without support.
Finding genetic variants that control genome-wide chromatin states is difficult with standard selection and needs focused experiments that perturb candidate factors one at a time.
“identifying genetic variants that regulate genome-wide chromatin states, which are challenging to isolate with standard selection protocols, requires focused experiments, where candidate factors are perturbed one-by-one.”
The authors state this as an assumption.
The expected accessibility change for a double perturbation under non-interaction is the product of the single perturbation effects, equivalent to adding their log2 fold changes.
“The additive expectation was based on a multiplicative model of non-interaction, (i.e., CRISPR AB = CRISPR A x CRISPR B), which we calculated by adding the single perturbation fold changes in log2-space.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Experimental manipulations of TF levels or mutagenesis of natural enhancers demonstrate that single TFs cause non-trivial increases and decreases of the activity of TF-bound enhancers.
“Experimental manipulations of TF levels24,25,26 or mutagenesis of natural enhancers27 demonstrate that single TFs cause non-trivial increases and decreases of the activity of TF-bound enhancers”
From Design principles of cell-state-specific enhancers in hematopoiesis (2025) · cites this paper as [25]
In Results, ‘Perturb-ATAC screen for TF control of cellular differentiation trajectories’ (page unavailable), ZNF750 disruption decreases accessibility at one ZNF750-bound enhancer and increases it at other ZNF750 binding sites. The Introduction describes ATAC-seq as measuring regulatory-element activity, but the Results do not establish that the sites gaining accessibility are enhancers; that part of the claim is less directly supported. (LLM, conf=0.83)
Experimental — accuracy not yet measuredMethods to capture changes in the epigenome following CRISPR perturbations have limited throughput.
“However, methods to capture changes in the epigenome following CRISPR perturbations have limited throughput6.”
From Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens (2021) · cites this paper as [6]
Some biological processes are better assayed using alternative modalities (splicing, chromatin, protein, imaging).
“In addition, some biological processes are better assayed using alternative modalities, including mRNA splicing, chromatin state, protein level, and imaging, all of which are now being studied at scale with single cell CRISPR screens39-44.”
From Transcriptome-wide analysis of differential expression in perturbation atlases (2025) · cites this paper as [39]
Perturb-ATAC combines genome-wide chromatin accessibility profiling in single cells based on simultaneous detection of CRISPR guide RNAs and open chromatin sites by ATAC-seq and multiplexed CRISPR interference or knockout.
“Additionally, Perturb-ATAC [19] combines genome-wide chromatin accessibility profiling in single cells based on the simultaneous detection of CRISPR guide RNAs and open chromatin sites by assaying transposase-accessible chromatin with sequencing (ATAC-seq) and multiplexed CRISPR interference or knockout (KO).”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Synergy example switches transcription-factor pairs
MinorThe text identifies EHF-ZNF750 as the high-synergy pair, then presents a dual EHF-JUNB knockout as an example of "this synergy." It is therefore unclear which pair the TP63 example is intended to support.
“EHF and JUNB had relatively low synergy, in contrast to the high synergy observed for EHF and ZNF750.”
“This synergy was particularly apparent at motif sites for TP63, a master regulator of epidermal homeostasis and differentiation, with dual EHF and JUNB knockout cells increasing TP63 accessibility far more than would be predicted from the single knockouts”
RT primer mix has incompatible concentrations
MinorThe same RT primer mix is described as 6 pM and as containing each sequencing oligo at 6 μM. A mix containing an oligo at 6 μM cannot have a total primer concentration of 6 pM.
“3.7μL 6 pM RT primer mix”
“6uM each of V1 GBC sequencing oligos or 6uM each of V1 sgRNA sequencing oligos”
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · see citing works
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437 · see citing works
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386 · see citing works
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · see citing works
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055 · see citing works
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422 · see citing works
Self-citationIntegrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368 · see citing works
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239 · see citing works
Reversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070 · see citing works
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · see citing works
Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells
Klein, A. M., Mazutis, L., Akartuna, I., Tallapragada, N., Veres, A., Li, V., Peshkin, L., Weitz, D. A., & Kirschner, M. W. (2015) · Cell · doi:10.1016/j.cell.2015.04.044 · Cited by 3,356 · see citing works
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
Corces, M. R., Trevino, A. E., Hamilton, E. G., Greenside, P. G., Sinnott-Armstrong, N. A., Vesuna, S., Satpathy, A. T., Rubin, A. J., Montine, K. S., Wu, B., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4396 · Cited by 2,496 · see citing works
Self-citationSingle-cell chromatin accessibility reveals principles of regulatory variation
Buenrostro, J. D., Wu, B., Litzenburger, U. M., Ruff, D., Gonzales, M. L., Snyder, M. P., Chang, H. Y., & Greenleaf, W. J. (2015) · Nature · doi:10.1038/nature14590 · Cited by 2,308 · see citing works
Self-citationA unique chromatin signature uncovers early developmental enhancers in humans
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A., & Wysocka, J. (2011) · Nature · doi:10.1038/nature09692 · Cited by 2,233 · see citing works
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162 · see citing works
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956 · see citing works
Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G., Park, J. S., Blackburn, E. H., Weissman, J. S., Qi, L. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.12.001 · Cited by 1,931 · see citing works
Dixit, A., Parnas, O., Li, B., Chen, J., Fulco, C. P., Jerby-Arnon, L., Marjanovic, N. D., Dionne, D., Burks, T., Raychowdhury, R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.038 · Cited by 1,863 · see citing works
chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data
Schep, A. N., Wu, B., Buenrostro, J. D., & Greenleaf, W. J. (2017) · Nature Methods · doi:10.1038/nmeth.4401 · Cited by 1,680 · see citing works
Self-citationRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
The IRF Family Transcription Factors in Immunity and Oncogenesis
Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259 · see citing works
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Engreitz, J. M., Haines, J. E., Perez, E. M., Munson, G., Chen, J., Kane, M., McDonel, P. E., Guttman, M., & Lander, E. S. (2016) · Nature · doi:10.1038/nature20149 · Cited by 1,253 · see citing works
Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing
Cusanovich, D. A., Daza, R., Adey, A., Pliner, H. A., Christiansen, L., Gunderson, K. L., Steemers, F. J., Trapnell, C., & Shendure, J. (2015) · Science · doi:10.1126/science.aab1601 · Cited by 1,248 · see citing works
Adamson, B., Norman, T. M., Jost, M., Cho, M. Y., Nuñez, J. K., Chen, Y., Villalta, J. E., Gilbert, L. A., Horlbeck, M. A., Hein, M. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.048 · Cited by 1,193 · see citing works
Corces, M. R., Buenrostro, J. D., Wu, B., Greenside, P. G., Chan, S. M., Koenig, J. L., Snyder, M. P., Pritchard, J. K., Kundaje, A., Greenleaf, W. J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3646 · Cited by 1,151 · see citing works
Self-citationA rapid and robust method for single cell chromatin accessibility profiling
Chen, X., Miragaia, R. J., Natarajan, K. N., & Teichmann, S. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07771-0 · Cited by 1,147 · see citing works
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · see citing works
Pooled CRISPR screening with single-cell transcriptome readout.
Datlinger, P., Rendeiro, A. F., Schmidl, C., Krausgruber, T., Traxler, P., Klughammer, J., Schuster, L. C., Kuchler, A., Alpar, D., & Bock, C. (2017) · Nature Methods · doi:10.1038/nmeth.4177 · Cited by 1,096 · see citing works
Transcriptional control of the inflammatory response
Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035 · see citing works
Control of somatic tissue differentiation by the long non-coding RNA TINCR
Kretz, M., Siprashvili, Z., Chu, C., Webster, D., Zehnder, A., Qu, K., Lee, C. S., Flockhart, R., Groff, A., Chow, J. M., et al. (2012) · Nature · doi:10.1038/nature11661 · Cited by 920 · see citing works
Self-citationDissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq
Jaitin, D. A., Weiner, A., Yofe, I., Lara-Astiaso, D., Keren-Shaul, H., David, E., Salame, T. M., Tanay, A., van Oudenaarden, A., & Amit, I. (2016) · Cell · doi:10.1016/j.cell.2016.11.039 · Cited by 777 · see citing works
Chromatin state dynamics during blood formation
Lara-Astiaso, D., Weiner, A., Lorenzo-Vivas, E., Zaretsky, I., Jaitin, D. A., David, E., Keren-Shaul, H., Mildner, A., Winter, D., Jung, S., et al. (2014) · Science · doi:10.1126/science.1256271 · Cited by 776 · see citing works
Kaikkonen, M. U., Spann, N. J., Heinz, S., Romanoski, C. E., Allison, K. A., Stender, J. D., Chun, H. B., Tough, D. F., Prinjha, R. K., Benner, C., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.010 · Cited by 672 · see citing works
Buenrostro, J. D., Corces, M. R., Lareau, C. A., Wu, B., Schep, A. N., Aryee, M. J., Majeti, R., Chang, H. Y., & Greenleaf, W. J. (2018) · Cell · doi:10.1016/j.cell.2018.03.074 · Cited by 670 · see citing works
Self-citationMumbach, M. R., Satpathy, A. T., Boyle, E. A., Dai, C., Gowen, B. G., Cho, S. W., Nguyen, M. L., Rubin, A. J., Granja, J. M., Kazane, K. R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3963 · Cited by 490 · see citing works
Self-citationSingle-cell analysis tools for drug discovery and development
Heath, J. R., Ribas, A., & Mischel, P. S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.16 · Cited by 473 · see citing works
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element
Cho, S. W., Xu, J., Sun, R., Mumbach, M. R., Carter, A. C., Chen, Y. G., Yost, K. E., Kim, J., He, J., Nevins, S. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.068 · Cited by 459 · see citing works
Self-citationThe Transcriptional Regulation of B Cell Lineage Commitment
Nutt, S. L., & Kee, B. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.010 · Cited by 384 · see citing works
Schep, A. N., Buenrostro, J. D., Denny, S. K., Schwartz, K., Sherlock, G., & Greenleaf, W. J. (2015) · Genome Research · doi:10.1101/gr.192294.115 · Cited by 375 · see citing works
Self-citationThe cis-regulatory dynamics of embryonic development at single-cell resolution
Cusanovich, D. A., Reddington, J. P., Garfield, D. A., Daza, R. M., Aghamirzaie, D., Marco-Ferreres, R., Pliner, H. A., Christiansen, L., Qiu, X., Steemers, F. J., et al. (2018) · Nature · doi:10.1038/nature25981 · Cited by 363 · see citing works
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351 · see citing works
EB virus‐encoded RNAs are recognized by RIG‐I and activate signaling to induce type I IFN
Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T., & Takada, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601314 · Cited by 313 · see citing works
Rubin, A. J., Barajas, B. C., Furlan-Magaril, M., Lopez-Pajares, V., Mumbach, M. R., Howard, I., Kim, D. S., Boxer, L. D., Cairns, J., Spivakov, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3935 · Cited by 293 · see citing works
Self-citationOrthologous CRISPR–Cas9 enzymes for combinatorial genetic screens
Najm, F. J., Strand, C., Donovan, K. F., Hegde, M., Sanson, K. R., Vaimberg, E. W., Sullender, M. E., Hartenian, E., Kalani, Z., Fusi, N., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4048 · Cited by 279 · see citing works
Scott, E. W., Fisher, R. C., Olson, M. C., Kehrli, E. W., Simon, M. C., & Singh, H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80287-3 · Cited by 270 · see citing works
On the design of CRISPR-based single-cell molecular screens
Hill, A. J., McFaline-Figueroa, J. L., Starita, L. M., Gasperini, M. J., Matreyek, K. A., Packer, J., Jackson, D., Shendure, J., & Trapnell, C. (2018) · Nature Methods · doi:10.1038/nmeth.4604 · Cited by 262 · see citing works
Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution
Vierstra, J. D., Rynes, E., Sandstrom, R. S., Zhang, M., Canfield, T. K., Hansen, R. S., Stehling-Sun, S., Sabo, P. J., Byron, R., Humbert, R., et al. (2014) · Science · doi:10.1126/science.1246426 · Cited by 253 · see citing works
ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation
Sen, G. L., Boxer, L. D., Webster, D. E., Bussat, R. T., Qu, K., Zarnegar, B. J., Johnston, D., Siprashvili, Z., & Khavari, P. A. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.12.001 · Cited by 246 · see citing works
Self-citationA LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation
Lopez-Pajares, V., Qu, K., Zhang, J., Webster, D. E., Barajas, B. C., Siprashvili, Z., Zarnegar, B. J., Boxer, L. D., Rios, E. J., Tao, S., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.028 · Cited by 194 · see citing works
Self-citationBao, X., Rubin, A. J., Qu, K., Zhang, J., Giresi, P. G., Chang, H. Y., & Khavari, P. A. (2015) · Genome Biology · doi:10.1186/s13059-015-0840-9 · Cited by 164 · see citing works
Self-citationThe NF-κB Genomic Landscape in Lymphoblastoid B Cells
Zhao, B., Barrera, L. A., Ersing, I., Willox, B., Schmidt, S. C. S., Greenfeld, H., Zhou, H., Mollo, S. B., Shi, T. T., Takasaki, K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.037 · Cited by 157 · see citing works
EBV Noncoding RNA Binds Nascent RNA to Drive Host PAX5 to Viral DNA
Lee, N., Moss, W. N., Yario, T. A., & STEITZ, J. A. (2015) · Cell · doi:10.1016/j.cell.2015.01.015 · Cited by 154 · see citing works
Dual gene activation and knockout screen reveals directional dependencies in genetic networks
Boettcher, M., Tian, R., Blau, J. A., Markegard, E., Wagner, R. T., Wu, D., Mo, X., Biton, A., Zaitlen, N., Fu, H., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4062 · Cited by 152 · see citing works
Transcript-indexed ATAC-seq for precision immune profiling
Satpathy, A. T., Saligrama, N., Buenrostro, J. D., Wei, Y., Wu, B., Rubin, A. J., Granja, J. M., Lareau, C. A., Li, R., Qi, Y., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0008-8 · Cited by 152 · see citing works
Self-citationHigh-throughput chromatin accessibility profiling at single-cell resolution
Mezger, A., Klemm, S. L., Mann, I. K., Brower, K. K., Mir, A. A., Bostick, M. L., Farmer, A. A., Fordyce, P. M., Linnarsson, S., & Greenleaf, W. J. (2018) · Nature Communications · doi:10.1038/s41467-018-05887-x · Cited by 149 · see citing works
Self-citationBoxer, L. D., Barajas, B., Tao, S., Zhang, J., & Khavari, P. A. (2014) · Genes & Development · doi:10.1101/gad.246579.114 · Cited by 147 · see citing works
Self-citationRegulation of Lymphoid versus Myeloid Fate 'choice' by the Transcription Factor Mef2c
Stehling-Sun, S., Dade, J., Nutt, S. L., DeKoter, R. P., & Camargo, F. D. (2009) · Nature Immunology · doi:10.1038/ni.1694 · Cited by 125 · see citing works
Yang, X., Lü, H., Yan, B., Romano, R.-A., Bian, Y., Friedman, J., Duggal, P., Allen, C. T., Chuang, R. J., Ehsanian, R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3445 · Cited by 122 · see citing works
Kreslavsky, T., Vilagos, B., Tagoh, H., Kostanova‐Poliakova, D., Schwickert, T. A., Wöhner, M., Jaritz, M., Weiß, S., Taneja, R., Rossner, M. J., et al. (2017) · Nature Immunology · doi:10.1038/ni.3694 · Cited by 119 · see citing works
AP1 Transcription Factors in Epidermal Differentiation and Skin Cancer
Eckert, R. L., Adhikary, G., Young, C. A., Jans, R., Crish, J. F., Xu, W., & Rorke, E. A. (2013) · Journal of Skin Cancer · doi:10.1155/2013/537028 · Cited by 118 · see citing works
Ma, S., Pathak, S., Trinh, L. X., & Lu, R. (2007) · Blood · doi:10.1182/blood-2007-08-110106 · Cited by 117 · see citing works
The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M., Chen, H. M., & Simon, M. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.203 · Cited by 113 · see citing works
7SK-BAF axis controls pervasive transcription at enhancers
Flynn, R. A., Do, B. T., Rubin, A. J., Calo, E., Lee, B., Kuchelmeister, H. Y., Rale, M. J., Chu, C., Kool, E. T., Wysocka, J., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3176 · Cited by 112 · see citing works
Self-citationLopez, R. G., Garcia-Silva, S., Moore, S. J., Bereshchenko, O., Martinez-Cruz, A. B., Ermakova, O., Kurz, E., Paramio, J. M., & Nerlov, C. (2009) · Nature Cell Biology · doi:10.1038/ncb1960 · Cited by 106 · see citing works
Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas
Lunning, M. A., & Green, M. R. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.89 · Cited by 102 · see citing works
Arrand, J. R., Young, L. S., & Tugwood, J. D. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.983-986.1989 · Cited by 98 · see citing works
Chen, X., Litzenburger, U. M., Wei, Y., Schep, A. N., LaGory, E. L., Choudhry, H., Giaccia, A. J., Greenleaf, W. J., & Chang, H. Y. (2018) · Nature Communications · doi:10.1038/s41467-018-07115-y · Cited by 80 · see citing works
Self-citationKallikrein 8 Is Involved in Skin Desquamation in Cooperation with Other Kallikreins
Kishibe, M., Bandô, Y., Terayama, R., Namikawa, K., Takahashi, H., Hashimoto, Y., Ishida‐Yamamoto, A., Jiang, Y., Mitrovic, B., Perez, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607998200 · Cited by 71 · see citing works
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia
Pang, S. H. M., Minnich, M., Gangatirkar, P., Zheng, Z., Ebert, A., Song, G., Dickins, R. A., Corcoran, L. M., Mullighan, C. G., Busslinger, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.27 · Cited by 69 · see citing works
Frequent sgRNA-barcode recombination in single-cell perturbation assays
Xie, S., Cooley, A., Armendariz, D., Zhou, P., & Hon, G. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198635 · Cited by 63 · see citing works
Feldman, D., Singh, A., Garrity, A. J., & Blainey, P. C. (2018) · doi:10.1101/262121 · Cited by 49 · see citing works
Epigenetic control of hematopoiesis: the PU.1 chromatin connection
van Riel, B., & Rosenbauer, F. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0195 · Cited by 47 · see citing works
Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneityPreprint
Liu, L., Liu, C., Quintero, A., Wu, L. L., Yuan, Y., Wang, M., Cheng, M., Leng, L., Xu, L., Dong, G., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/316208 · Cited by 37 · see citing works
Approaches to maximize sgRNA-barcode coupling in Perturb-seq screens
Adamson, B., Norman, T. M., Jost, M., & Weissman, J. S. (2018) · doi:10.1101/298349 · Cited by 34 · see citing works
Disruption of epidermal specific gene expression and delayed skin development in AP-2γ mutant mice
Guttormsen, J., Koster, M. I., Stevens, J. R., Roop, D. R., Williams, T., & Winger, Q. A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.017 · Cited by 33 · see citing works
Buenrostro, J. D., Corces, M. R., Wu, B., Schep, A. N., Lareau, C. A., Majeti, R., Chang, H. Y., & Greenleaf, W. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/109843 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
1 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Single-cell chromatin state analysis with Signac
Stuart, T., Srivastava, A., Madad, S., Lareau, C. A., & Satija, R. (2021) · Nature Methods · doi:10.1038/s41592-021-01282-5 · Cited by 1,769 · see citing works
Methods and applications for single-cell and spatial multi-omics
Vandereyken, K., Sifrim, A., Thienpont, B., & Voet, T. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00580-2 · Cited by 1,244 · see citing works
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117 · see citing works
Self-citationCRISPR technology: A decade of genome editing is only the beginning
Wang, J. Y., & Doudna, J. A. (2023) · Science · doi:10.1126/science.add8643 · Cited by 1,058 · see citing works
Satpathy, A. T., Granja, J. M., Yost, K. E., Qi, Y., Meschi, F., McDermott, G. P., Olsen, B. N., Mumbach, M. R., Pierce, S. E., Corces, M. R., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0206-z · Cited by 980 · see citing works
Self-citationMapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq
Replogle, J. M., Saunders, R. A., Pogson, A. N., Hussmann, J. A., Lenail, A., Guna, A., Mascibroda, L., Wagner, E. J., Adelman, K., Lithwick-Yanai, G., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.013 · Cited by 751 · see citing works
Bock, C., Datlinger, P., Chardon, F. M., Coelho, M. A., Dong, M. B., Lawson, K. A., Lu, T., Maroc, L., Norman, T. M., Song, B., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00093-4 · Cited by 591 · see citing works
Mimitou, E. P., Lareau, C. A., Chen, K. Y., Zorzetto-Fernandes, A. L., Hao, Y., Takeshima, Y., Luo, W., Huang, T.-S., Yeung, B. Z., Papalexi, E., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00927-2 · Cited by 529 · see citing works
Computational principles and challenges in single-cell data integration
Argelaguet, R., Cuomo, A. S. E., Stegle, O., & Marioni, J. C. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00895-7 · Cited by 472 · see citing works
Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing
Replogle, J. M., Norman, T. M., Xu, A., Hussmann, J. A., Chen, J., Cogan, J. Z., Meer, E. J., Terry, J. M., Riordan, D. P., Srinivas, N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0470-y · Cited by 465 · see citing works
Comprehensive analysis of single cell ATAC-seq data with SnapATAC
Fang, R., Preissl, S., Li, Y., Hou, X., Lucero, J., Wang, X., Motamedi, A., Shiau, A. K., Zhou, X., Xie, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21583-9 · Cited by 455 · see citing works
Single-cell multimodal omics: the power of many
Zhu, C., Preissl, S., & Ren, B. (2020) · Nature Methods · doi:10.1038/s41592-019-0691-5 · Cited by 386 · see citing works
Optical Pooled Screens in Human Cells
Feldman, D., Singh, A., Schmid-Burgk, J. L., Carlson, R. J., Mezger, A., Garrity, A. J., Zhang, F., & Blainey, P. C. (2019) · Cell · doi:10.1016/j.cell.2019.09.016 · Cited by 321 · see citing works
Epigenetic regulation of T cell exhaustion
Belk, J. A., Dániel, B., & Satpathy, A. T. (2022) · Nature Immunology · doi:10.1038/s41590-022-01224-z · Cited by 334 · see citing works
Self-citationIn vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes
Jin, X., Simmons, S. K., Guo, A., Shetty, A. S., Ko, M., Nguyen, L., Jokhi, V., Robinson, E., Oyler, P., Curry, N., et al. (2020) · Science · doi:10.1126/science.aaz6063 · Cited by 317 · see citing works
A new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281 · see citing works
Integrative Methods and Practical Challenges for Single-Cell Multi-omics
Ma, A., McDermaid, A., Xu, J., Chang, Y., & Ma, Q. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.02.013 · Cited by 272 · see citing works
Bock, C., Datlinger, P., Chardon, F. M., Coelho, M. A., Dong, M. B., Lawson, K. A., Lu, T., Maroc, L., Norman, T. M., Song, B., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00098-7 · Cited by 254 · see citing works
Functional inference of gene regulation using single-cell multi-omics
Kartha, V. K., Duarte, F. M., Hu, Y., Ma, S., Chew, J. G., Lareau, C. A., Earl, A., Burkett, Z. D., Kohlway, A. S., Lebofsky, R., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100166 · Cited by 224 · see citing works
Papalexi, E., Mimitou, E. P., Butler, A. W., Foster, S., Bracken, B., Mauck, W. M., Wessels, H.-H., Hao, Y., Yeung, B. Z., Smibert, P., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00778-2 · Cited by 238 · see citing works
Synergistic effects of common schizophrenia risk variants
Schrode, N., Ho, S., Yamamuro, K., Dobbyn, A. L., Huckins, L. M., Matos, M. R., Cheng, E., Deans, P. J. M., Flaherty, E. K., Barretto, N., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0497-5 · Cited by 223 · see citing works
Genomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 229 · see citing works
B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells
Yu, B., Qi, Y., Li, R., Shi, Q., Satpathy, A. T., & Chang, H. Y. (2021) · Cell · doi:10.1016/j.cell.2021.02.015 · Cited by 217 · see citing works
Self-citationChromatin accessibility profiling methods
Minnoye, L., Marinov, G. K., Krausgruber, T., Pan, L., Marand, A. P., Secchia, S., Greenleaf, W. J., Furlong, E. E. M., Zhao, K., Schmitz, R. J., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-020-00008-9 · Cited by 206 · see citing works
Self-citationHOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice
Luo, H., Zhu, G., Xu, J., Lai, Q., Yan, B., Guo, Y., Fung, T. K., Zeisig, B. B., Cui, Y., Zha, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.011 · Cited by 192 · see citing works
scPerturb: harmonized single-cell perturbation data
Peidli, S., Green, T. D., Shen, C., Gross, T., Min, J., Garda, S., Yuan, B., Schumacher, L. J., Taylor-King, J. P., Marks, D. S., et al. (2024) · Nature Methods · doi:10.1038/s41592-023-02144-y · Cited by 194 · see citing works
The road ahead in genetics and genomics
McGuire, A. L., Gabriel, S., Tishkoff, S. A., Wonkam, A., Chakravarti, A., Furlong, E. E. M., Treutlein, B., Meissner, A., Chang, H. Y., López-Bigas, N., et al. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0272-6 · Cited by 188 · see citing works
Self-citationThe evolving concept of cell identity in the single cell era
Morris, S. A. (2019) · Development · doi:10.1242/dev.169748 · Cited by 154 · see citing works
Pierce, S. E., Granja, J. M., & Greenleaf, W. J. (2021) · Nature Communications · doi:10.1038/s41467-021-23213-w · Cited by 146 · see citing works
Self-citationSingle-cell ATAC sequencing analysis: From data preprocessing to hypothesis generation
Baek, S., & Lee, I. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.012 · Cited by 151 · see citing works
Multimodal single-cell chromatin analysis with SignacPreprint
Stuart, T., Srivastava, A., Lareau, C. A., & Satija, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.09.373613 · Cited by 150 · see citing works
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements
Tycko, J., Wainberg, M., Marinov, G. K., Ursu, O., Hess, G. T., Ego, B. K., Aradhana, Li, A., Truong, A., Trevino, A. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11955-7 · Cited by 144 · see citing works
Self-citationHOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia
Luo, H., Zhu, G., Eshelman, M. A., Fung, T. K., Lai, Q., Wang, F., Zeisig, B. B., Lesperance, J., Ma, X., Shi, C., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.014 · Cited by 145 · see citing works
Rood, J. E., Hupalowska, A., & Regev, A. (2024) · Cell · doi:10.1016/j.cell.2024.07.035 · Cited by 139 · see citing works
A practical view of fine-mapping and gene prioritization in the post-genome-wide association era
Broekema, R., Bakker, O. B., & Jonkers, I. H. (2020) · Open Biology · doi:10.1098/rsob.190221 · Cited by 127 · see citing works
Immune cell profiling in atherosclerosis: role in research and precision medicine
Fernandez, D. M., & Giannarelli, C. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00589-2 · Cited by 124 · see citing works
Single cell cancer epigenetics
Casado-Peláez, M., Bueno-Costa, A., & Esteller, M. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.005 · Cited by 113 · see citing works
Accelerating the understanding of cancer biology through the lens of genomics
Wang, D., Liu, B., & Zhang, Z. (2023) · Cell · doi:10.1016/j.cell.2023.02.015 · Cited by 113 · see citing works
Liscovitch-Brauer, N., Montalbano, A., Deng, J., Méndez-Mancilla, A., Wessels, H.-H., Moss, N. G., Kung, C.-Y., Sookdeo, A., Guo, X., Geller, E., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00902-x · Cited by 107 · see citing works
CRISPR technologies for stem cell engineering and regenerative medicine
Hsu, M., Chang, Y., Truong, V. A., Lai, P., Nguyen, T. K. N., & Hu, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107447 · Cited by 105 · see citing works
Epidermal structure and differentiation
Moreci, R. S., & Lechler, T. (2020) · Current Biology · doi:10.1016/j.cub.2020.01.004 · Cited by 99 · see citing works
Le, J., Dian, Y., Zhao, D., Guo, Z., Luo, Z., Chen, X., Zeng, F., & Deng, G. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02426-3 · Cited by 109 · see citing works
Freimer, J. W., Shaked, O., Naqvi, S., Sinnott-Armstrong, N., Kathiria, A. S., Garrido, C. M., Chen, A. F., Cortez, J. T., Greenleaf, W. J., Pritchard, J. K., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01106-y · Cited by 93 · see citing works
Self-citationCRISPR screens for functional interrogation of immunity
Shi, H., Doench, J. G., & Chi, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00802-4 · Cited by 96 · see citing works
scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens
Yang, L., Zhu, Y., Yu, H., Cheng, X., Chen, S., Chu, Y., Huang, H., Zhang, J., & Li, W. (2020) · Genome Biology · doi:10.1186/s13059-020-1928-4 · Cited by 94 · see citing works
Distribution and storage of inflammatory memory in barrier tissues
Ordovas-Montañes, J., Beyaz, S., Rakoff-Nahoum, S., & Shalek, A. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-019-0263-z · Cited by 85 · see citing works
Bravo González‐Blas, C., Quan, X., Duran‐Romaña, R., Taskiran, I. I., Koldere, D., Davie, K., Christiaens, V., Makhzami, S., Hulselmans, G., de Waegeneer, M., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209438 · Cited by 88 · see citing works
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Awwad, S. W., Serrano-Benítez, A., Thomas, J. C., Gupta, V., & Jackson, S. P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00571-x · Cited by 87 · see citing works
High-content imaging-based pooled CRISPR screens in mammalian cells
Yan, X., Stuurman, N., Ribeiro, S. A., Tanenbaum, M. E., Horlbeck, M. A., Liem, C. R., Jost, M., Weissman, J. S., & Vale, R. D. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202008158 · Cited by 83 · see citing works
Zheng, X., Wu, B., Liu, Y., Simmons, S., Kim, K., Clarke, G. S., Ashiq, A., Park, J. C., Li, J., Wang, Z., et al. (2024) · Cell · doi:10.1016/j.cell.2024.04.050 · Cited by 80 · see citing works
Self-citationLearning causal networks using inducible transcription factors and transcriptome‐wide time series
Hackett, S. R., Baltz, E. A., Coram, M., Wranik, B. J., Kim, G., Baker, A., Fan, M., Hendrickson, D. G., Berndl, M., & McIsaac, R. S. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199174 · Cited by 75 · see citing works
Single-cell omics: experimental workflow, data analyses and applications
Sun, F., Li, H., Sun, D., Fu, S., Gu, L., Shao, X., Wang, Q., Dong, X., Duan, B., Xing, F., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2561-0 · Cited by 81 · see citing works
Immunology in the Era of Single-Cell Technologies
Efremova, M., Vento‐Tormo, R., Park, J.-E., Teichmann, S. A., & James, K. R. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090419-020340 · Cited by 77 · see citing works
Invited Review: Epigenetics in neurodevelopment
Salinas, R. D., Connolly, D. R., & Song, H. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12608 · Cited by 81 · see citing works
The dynamic, combinatorial cis-regulatory lexicon of epidermal differentiation
Kim, D. S., Risca, V. I., Reynolds, D., Chappell, J., Rubin, A. J., Jung, N., Donohue, L., Lopez-Pajares, V., Kathiria, A. S., Shi, M.-Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-021-00947-3 · Cited by 79 · see citing works
Self-citationZhu, G., Luo, H., Feng, Y., Guryanova, O. A., Xu, J., Shi, C., Lai, Q., Sharma, A. K., Xu, B., Zhao, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22095-2 · Cited by 78 · see citing works
Interpreting non-coding disease-associated human variants using single-cell epigenomics
Gaulton, K. J., Preißl, S., & Ren, B. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00598-6 · Cited by 79 · see citing works
Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation
Miao, W., Porter, D. F., Lopez-Pajares, V., Siprashvili, Z., Meyers, R. M., Bai, Y., Nguyen, D. T., Ko, L. A., Zarnegar, B. J., Ferguson, I., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.004 · Cited by 75 · see citing works
Self-citationSynthetic lethal strategies for the development of cancer therapeutics
Ngoi, N. Y. L., Gallo, D., Torrado, C., Nardo, M., Durocher, D., & Yap, T. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00966-z · Cited by 78 · see citing works
Exploring the untapped potential of single‐cell and spatial omics in plant biology
Nobori, T. (2025) · New Phytologist · doi:10.1111/nph.70220 · Cited by 78 · see citing works
A plate-based single-cell ATAC-seq workflow for fast and robust profiling of chromatin accessibility
Xu, W., Wen, Y., Liang, Y., Xu, Q., Wang, X., Jin, W., & Chen, X. (2021) · Nature Protocols · doi:10.1038/s41596-021-00583-5 · Cited by 67 · see citing works
Transcriptome-wide analysis of differential expression in perturbation atlases
Nadig, A., Replogle, J. M., Pogson, A. N., Murthy, M., McCarroll, S. A., Weissman, J. S., Robinson, E. B., & O’Connor, L. J. (2025) · Nature Genetics · doi:10.1038/s41588-025-02169-3 · Cited by 70 · see citing works
Gene editing and its applications in biomedicine
Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 65 · see citing works
Hsu, M., Huang, K.-L., Yu, F.-J., Lai, P., Truong, V. A., Lin, M., Nguyen, N. T. K., Shen, C., Hwang, S., Chang, Y., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.029 · Cited by 67 · see citing works
Advances and applications in single-cell and spatial genomics
Wang, J., Ye, F., Chai, H., Jiang, Y., Wang, T., Ran, X., Xia, Q., Xu, Z., Fu, Y., Zhang, G., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2770-x · Cited by 69 · see citing works
Gene regulatory network inference in single-cell biology
Akers, K., & Murali, T. M. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.04.007 · Cited by 63 · see citing works
Finnegan, A., Cho, R. J., Luu, A., Harirchian, P., Lee, J. S. H., Cheng, J. B., & Song, J. S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00775 · Cited by 63 · see citing works
Rethinking cancer targeting strategies in the era of smart cell therapeutics
Allen, G. M., & Lim, W. A. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00505-x · Cited by 59 · see citing works
Pooled genetic perturbation screens with image-based phenotypes
Feldman, D., Funk, L., Le, A., Carlson, R. J., Leiken, M. D., Tsai, F., Soong, B., Singh, A., & Blainey, P. C. (2022) · Nature Protocols · doi:10.1038/s41596-021-00653-8 · Cited by 59 · see citing works
Jiang, L., Dalgarno, C., Papalexi, E., Mascio, I., Wessels, H., Yun, H., Iremadze, N., Lithwick‐Yanai, G., Lipson, D., & Satija, R. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01622-z · Cited by 62 · see citing works
Tn5 Transposase Applied in Genomics Research
Li, N., Jin, K., Bai, Y., Fu, H., Liu, L., & Liu, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218329 · Cited by 56 · see citing works
Integrating machine learning and genome editing for crop improvement
Chen, L., Liu, G., & Zhang, T. (2024) · aBIOTECH · doi:10.1007/s42994-023-00133-5 · Cited by 58 · see citing works
A mini-review on perturbation modelling across single-cell omic modalities
Gavriilidis, G. I., Vasileiou, V., Orfanou, A., Ishaque, N., & Psomopoulos, F. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.058 · Cited by 54 · see citing works
Murphy, D., Salataj, E., Giammartino, D. C. D., Rodriguez-Hernaez, J., Kloetgen, A., Garg, V., Char, E., Uyehara, C. M., Ee, L.-S., Lee, U., et al. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01130-4 · Cited by 47 · see citing works
Emerging roles for endogenous retroviruses in immune epigenetic regulation*
Buttler, C. A., & Chuong, E. B. (2021) · Immunological Reviews · doi:10.1111/imr.13042 · Cited by 49 · see citing works
Profiling Chromatin Accessibility at Single-Cell Resolution
Sinha, S., Satpathy, A. T., Zhou, W., Ji, H., Stratton, J. A., Jaffer, A., Bahlis, N. J., Morrissy, A. S., & Biernaskie, J. A. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.06.010 · Cited by 47 · see citing works
Self-citationBidirectional epigenetic editing reveals hierarchies in gene regulation
Pacalin, N. M., Steinhart, Z., Shi, Q., Belk, J. A., Dorovskyi, D., Kraft, K., Parker, K. R., Shy, B. R., Marson, A., & Chang, H. Y. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02213-3 · Cited by 48 · see citing works
Self-citationTime for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease
Joseph, S. A., Taglialatela, A., Leuzzi, G., Huang, J., Cuella-Martin, R., & Ciccia, A. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102943 · Cited by 47 · see citing works
Moysés‐Oliveira, M., Yadav, R., Erdin, S., & Talkowski, M. E. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.07.001 · Cited by 45 · see citing works
CRISPR based therapeutics: a new paradigm in cancer precision medicine
Das, S., Bano, S., Kapse, P., & Kundu, G. C. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01552-6 · Cited by 45 · see citing works
Technologies and Computational Analysis Strategies for CRISPR Applications
Clement, K., Hsu, J. Y., Canver, M. C., Joung, J. K., & Pinello, L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.012 · Cited by 44 · see citing works
Single-cell genomics to understand disease pathogenesis
Nomura, S. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-00844-3 · Cited by 44 · see citing works
Peñalosa-Ruiz, G., Bright, A. R., Mulder, K. W., & Veenstra, G. J. C. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194407 · Cited by 41 · see citing works
Gupta, A., Martin-Rufino, J. D., Jones, T. R., Subramanian, V., Qiu, X., Grody, E. I., Bloemendal, A., Weng, C., Niu, S.-Y., Min, K. H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207392119 · Cited by 42 · see citing works
Large-scale multiplexed mosaic CRISPR perturbation in the whole organism
Liu, B., Jing, Z., Zhang, X., Chen, Y., Mao, S., Kaundal, R. K., Zou, Y., Ge, W., Zang, Y., Wang, X., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.039 · Cited by 42 · see citing works
Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation
Janas, J. A., Zhang, L., Luu, J. H., Demeter, J., Meng, L., Marro, S. G., Mall, M., Mooney, N. A., Schaukowitch, K., Ng, Y. H., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.002 · Cited by 41 · see citing works
Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution
Cheng, J., Lin, G., Wang, T., Wang, Y., Guo, W., Liao, J., Yang, P., Chen, J., Shao, X., Lu, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202204484 · Cited by 40 · see citing works
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Liu, D., Zhao, X., Tang, A., Xu, X., Liu, S., Zha, L., Ma, W., Zheng, J., & Shi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188378 · Cited by 43 · see citing works
Naranjo, S., Cabana, C. M., LaFave, L. M., Romero, R., Shanahan, S.-L., Bhutkar, A. J., Westcott, P. M. K., Schenkel, J. M., Ghosh, A., Liao, L. Z., et al. (2022) · Genes & Development · doi:10.1101/gad.349659.122 · Cited by 40 · see citing works
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Zhang, L., Yang, J., Huang, J., Yu, Y., Ding, J., Karges, J., & Xiao, H. (2024) · Chem · doi:10.1016/j.chempr.2023.12.019 · Cited by 37 · see citing works
Perspectives on Epigenetics Alterations Associated with Smoking and Vaping
Xie, Z., Rahman, I., Goniewicz, M. L., & Li, D. (2021) · Function · doi:10.1093/function/zqab022 · Cited by 34 · see citing works
Valenzi, E., Bahudhanapati, H., Tan, J., Tabib, T., Sullivan, D. I., Nouraie, M. S., Sembrat, J., Fan, L., Chen, K., Liu, S., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00474-2022 · Cited by 34 · see citing works
Jin, L., Chen, Y., Muzaffar, S., Li, C., Mier-Aguilar, C. A., Khan, J., Kashyap, M. P., Liu, S., Srivastava, R. K., Deshane, J. S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315096120 · Cited by 32 · see citing works
Tagmentation-based single-cell genomicsPreprint
Adey, A. (2021) · Genome Research · doi:10.1101/gr.275223.121 · Cited by 32 · see citing works
AI-empowered perturbation proteomics for complex biological systems
Qian, L., Sun, R., Aebersold, R. H., Bühlmann, P., Sander, C., & Guo, T. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100691 · Cited by 31 · see citing works
Yang, X., Bayat, V., Donato, N. D., Zhao, Y., Zarnegar, B. J., Siprashvili, Z., Lopez-Pajares, V., Sun, T., Tao, S., Li, C., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz251 · Cited by 32 · see citing works
Self-citationApplications of Single-Cell Omics to Dissect Tumor Microenvironment
Guo, T., Li, W., & Cai, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.548719 · Cited by 33 · see citing works
Decoding heterogeneous single-cell perturbation responses
Song, B., Liu, D., Dai, W., McMyn, N. F., Wang, Q., Yang, D., Krejčí, A., Vasilyev, A., Untermoser, N., Loregger, A., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01626-9 · Cited by 36 · see citing works
Tumor immunology CRISPR screening: present, past, and future
Dong, M. B., Tang, K., Zhou, X., Zhou, J. J., & Chen, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.11.009 · Cited by 31 · see citing works
Pooled genetic screens with image‐based profiling
Walton, R. T., Singh, A. K., & Blainey, P. C. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110768 · Cited by 29 · see citing works
- Authors
- Rubin, A. J., Parker, K. R., Satpathy, A. T., Qi, Y., Wu, B., Ong, A. J., Mumbach, M. R., Ji, A. L., Kim, D. S., Cho, S. W., Zarnegar, B. J., Greenleaf, W. J., Chang, H. Y., & Khavari, P. A.
- Affiliations
- Stanford Medicine (US)
- Chan Zuckerberg Biohub San Francisco (US)
- Howard Hughes Medical Institute (US)
- VA Palo Alto Health Care System (US)
- Corresponding author
- Chang, Howard Y.
- Khavari, Paul A.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 176
- Issue
- 1-2
- Pages
- 361-376.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6329648
- OpenAlex
- W2950195808
- Cited by
- 314
- References
- 78
- Citations by year
- 2026: 31 · 2025: 50 · 2024: 40 · 2023: 37 · 2022: 52 · 2021: 44 · 2020: 42 · 2019: 17 · 2012: 1
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Funders
- Veterans Affairs Office of Research and Development
- NIH (AR45192, AR43799, P50-HG007735, R35-CA209919)
- Parker Institute for Cancer Immunotherapy
- Scleroderma Research Foundation
- Stanford Bio-X
- Stanford
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- CRISPR interference, CRISPR knockout, chromatin accessibility, gene regulatory networks, transcription factor occupancy, nucleosome positioning, cis-regulatory elements, B cells, epidermal cells, non-coding RNA, genotype-phenotype correlation
- MeSH terms
- Chromatin, Humans, Transcription Factors, Sequence Analysis, DNA, Chromatin Assembly and Disassembly, Gene Regulatory Networks, Epigenomics, Single-Cell Analysis, High-Throughput Nucleotide Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-04.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-04.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review